2016SITC共识声明：血液系统恶性肿瘤的免疫治疗.pdf

Boyiadzis et al. Journal for ImmunoTherapy of Cancer (2016) 4:90 DOI 10.1186/s40425-016-0188-z POSITION ARTICLE AND GUIDELINES Open Access The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia 1† 2† 3 4 5 Michael Boyiadzis , Michael R. Bishop , Rafat Abonour , Kenneth C. Anderson , Stephen M. Ansell , David Avigan6 7 8 9 10 11 , Lisa Barbarotta , Austin John Barrett , Koen Van Besien , P. Leif Bergsagel , Ivan Borrello , Joshua Brody 12, Jill Brufsky13, Mitchell Cairo14, Ajai Chari12, Adam Cohen15, Jorge Cortes16, Stephen J. Forman17, Jonathan W. Friedberg18, Ephraim J. Fuchs19, Steven D. Gore20, Sundar Jagannath12, Brad S. Kahl21, Justin Kline22, James N. Kochenderfer23, Larry W. Kwak24, Ronald Levy25, Marcos de Lima26, Mark R. Litzow27, Anuj Mahindra28, Jeffrey Miller29 30 31 32 33 5 , Nikhil C. Munshi , Robert Z. Orlowski , John M. Pagel , David L. Porter , Stephen J. Russell , 34 35 36 4 37 38 Karl Schwartz , Margaret A. Shipp , David Siegel , Richard M. Stone , Martin S. Tallman , John M. Timmerman , Frits Van Rhee39, Edmund K. Waller40, Ann Welsh41, Michael Werner42, Peter H. Wiernik43 and Madhav V. Dhodapkar44* Abstract Increasing knowledge concerning the biology